CRBU · Caribou Biosciences Inc
United States · RS rating 2 · As of 2026-10-14
| Price | 0.46 USD |
|---|---|
| 1-day change | -2.1% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 2 / 2 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 16 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +6.7% |
| Sales growth Q/Q | +79.3% |
| Distance from 52-week high | +83.8% |
| Market cap (USD) | $218.4M |